A 63-year-old lady underwent right-sided nephrectomy for renal cell carcinoma (RCC) in 1991. She required a further nephrectomy in 2003 for RCC in the contralateral side rendering her haemodialysis dependent. Following 2-year disease free survival she was considered for transplantation. An initial CT scan of the abdomen in 2005 raised the possibility of bone metastases, promoting further investigation; however, isotope bone scanning and MRI revealed degenerative changes only. Her oncologist advised yearly surveillance CT scans following transplant listing. Following the routine work-up she was activated on the UK transplant deceased donor waiting list.
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A CT scan in 2007 demonstrated two hyperdense lesions within the head and body of the pancreas, and a radioisotope octreotide scan was performed to exclude a non-functional neuroendocrine tumour. Appearances on the 24 and 48 h octreotide images demonstrated intense tracer accumulation within the left gluteus medius and the right-proximal vastus medialis muscles, confirmed on single photon emission computed tomography (SPECT) (Figure 1 ).
An ultrasound-guided muscle biopsy of the rightproximal vastus medialis muscle was performed which Following the diagnosis of in situ tumours such as RCC, European Best Practice Guidelines (EBPG) recommend a waiting time of at least 2 years before consideration for transplantation [1] . However, case reports have documented latency periods for recurrent RCC of up to 19 years [2] . Surveillance CT in this case proved to be useful.
Although skeletal muscle RCC metastases have been described, it is a rare occurrence. CT scanning is the method of choice in detecting usual sites of metastases [3] . In this case, skeletal muscle metastases were detected as an incidental finding as a result of investigating two hyperdense pancreatic lesions on CT.
RCC express somatostatin receptors that have the potential to be visualized with octreoscan scintigraphy [4] ; however, this appears to be the first case of skeletal muscle metastases being detected using octreotide scanning. 
